Checking a Questionnaire That Measures Patient Knowledge of Pulmonary Hypertension
Tests a questionnaire on pulmonary hypertension knowledge in adults with pulmonary arterial hypertension.
Plain-language title generated from the registry record
Registry title: Validation of a Patient Knowledge Questionnaire for Pulmonary Hypertension
Key facts
- Where
- São Paulo, BrazilSee the site
Where in Brazil
- Instituto do Coração InCor, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São PauloSão Paulo, BrazilTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Sao Paulo General Hospital
- Trial code
- NCT07120789
- Record updated
- 10 March 2026
- Original description
This methodological study aims to develop and validate a questionnaire named for the Assessment of Patient Knowledge in Pulmonary Arterial Hypertension. The study will be conducted in four phases: (1) questionnaire development based on guidelines and literature; (2) content validation by expert judges; (3) semantic validation with patients; and (4) psychometric testing in a sample of up to 200 patients with confirmed pulmonary arterial hypertension (PAH).Read full original descriptionShow less
Content, Semantic, and Psychometric Validation of a Patient Knowledge Questionnaire for Pulmonary Hypertension
This methodological study aims to develop and validate a questionnaire named for the Assessment of Patient Knowledge in Pulmonary Arterial Hypertension. The study will be conducted in four phases: (1) questionnaire development based on guidelines and literature; (2) content validation by expert judges; (3) semantic validation with patients; and (4) psychometric testing in a sample of up to 200 patients with confirmed pulmonary arterial hypertension (PAH).
In addition to validation, the study will collect clinical and functional data from medical records, including risk stratification using the COMPERA 2.0 method The final instrument is expected to support patient education strategies and contribute to improved clinical management of PAH.
Inclusion: Adults aged 18 years or older; Confirmed diagnosis of Group 1 Pulmonary Arterial Hypertension (PAH); Ability to read and understand the questionnaire language; Provided informed consent to participate in the study; For expert judges (content validation phase): professionals with recognized expertise in pulmonary hypertension, with academic or clinical experience in the field.
Exclusion: Cognitive, visual, or auditory impairments that hinder questionnaire comprehension; Refusal to participate or withdrawal of informed consent; Inability to complete the questionnaire due to clinical instability.